Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Przeglad Epidemiologiczny 2014

Scarlet fever in Poland in 2012.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
Ewa Staszewska
Barbara Kondej
Mirosław P Czarkowski

Märksõnad

Abstraktne

OBJECTIVE

Assessment of the epidemiological situation of scarlet fever in Poland in 2012.

METHODS

The evaluation was performed by analysing surveillance data published in the bulletin, "Infectious diseases and poisonings in Poland in 2012" (Warsaw 2013, NIPH-NIH, CSI) and also in bulletins from previous years, and unpublished data collected under Statistical survey program of official statistics.

RESULTS

In the last 15-20 years in Poland has been observed more than 2-fold lengthening of scarlet fever epidemic cycle, slowdown in the decline and slower growth rate in epidemic curve and decrease in average annual incidence. In 2012, in the country a total of 25 421 cases were registered and incidence was 66.0 per 100 000 population (in voivodeships: from 25.8 in łódzkie to 114.2 in pomorskie). The highest incidence was notified in 5-year-old (1094.7) and 6-year-old children (877.3), however, the incidence among children and young people up to 15 years accounted for 95.6% of all cases. The incidence of men (74.8) was higher by almost 30% than the incidence of women (57.6). The incidence was higher in urban areas than in rural areas and was 72.7 (in rural area 55.7). 0.9% of patients were hospitalized. No deaths related to the disease were reported.

CONCLUSIONS

Distinct changes in the epidemiological situation of scarlet fever in recent decades are related to, i.a., aging of the Polish population and decline in the number of children, group particularly vulnerable to infection. In order to improve accuracy of surveillance data, it is recommended significantly increase percentage of cases in which clinical diagnosis will be confirmed by the result of bacteriological examination.

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge